A case of diffuse large B-cell lymphoma with interstitial pneumonia

Ge Song,Changxi Zhou,Shuxia Wang,Tianqi Tao,Weiping Guan,Xuan Wu,Ping Zhu,Bo Yang,Xuechun Lu
DOI: https://doi.org/10.1016/j.cpt.2023.06.001
2023-06-19
Abstract:This report involves a 54-year-old female patient diagnosed with diffuse large B-cell lymphoma who developed interstitial pneumonia (IP) during treatment. The patient presented to the ward with enlarged lymph nodes in the neck and was treated with the standard regimen, which included rituximab, cyclophosphamide, doxorubicin liposomes, vincristine, and prednisone (R-CDOP regimen). After 3 cycles, the treatment was assessed as effective. However, following the 4th cycle, the patient experience shortness of breath after physical activity. A repeat lung computer tomography indicated IP, which completely recovered after receiving "full coverage" treatment. Subsequently, the patient underwent 2 cycles of cyclophosphamide, doxorubicin liposomes, vincristine, and prednisone (CDOP), followed by local radiotherapy. Currently, the patient is now being followed up with regular reviews.
What problem does this paper attempt to address?